TJX
62
-3
STI
7
2
CMA
65
-6
VNO
50
-2
GPC
53
-3
LRCX
71
22
ADI
72
2
EL
61
3
CCL
65
3
CNX
46
-3
PVH
30
-2
MUR
33
-5
KLAC
70
5
NRG
44
7
APA
48
-4
NWL
58
-3
ICE
57
-5
AN
43
-6
PHM
43
-3
AAP
1
-4
TJX
62
-3
STI
7
2
CMA
65
-6
VNO
50
-2
GPC
53
-3
LRCX
71
22
ADI
72
2
EL
61
3
CCL
65
3
CNX
46
-3
PVH
30
-2
MUR
33
-5
KLAC
70
5
NRG
44
7
APA
48
-4
NWL
58
-3
ICE
57
-5
AN
43
-6
PHM
43
-3
AAP
1
-4
Financhill
Back

Mackenzie Emerging Markets Equity Index ETF Vs. MiNK Therapeutics, Inc. Industry Stock Comparison

Buy
56

QEE.TO
Mackenzie Emerging Markets Equity Index ETF

Last Price:
$117.84
Seasonality Move:
2.21%
Sell
27

INKT
MiNK Therapeutics, Inc.

Last Price:
$11.68
Seasonality Move:
-18.07%
Buy
56
Mackenzie Emerging Markets Equity Index ETF (QEE.TO) is a Buy

Is Mackenzie Emerging Markets Equity Index ETF a Buy, Sell or Hold?

  • The current Mackenzie Emerging Markets Equity Index ETF [QEE.TO] share price is $117.65. The Score for QEE.TO is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • QEE.TO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
27
MiNK Therapeutics, Inc. (INKT) is a Sell

Is MiNK Therapeutics, Inc. a Buy, Sell or Hold?

  • The current MiNK Therapeutics, Inc. [INKT] share price is $11.53. The Score for INKT is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • INKT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QEE.TO Stock Price Chart

What is Mackenzie Emerging Markets Equity Index ETF's stock price today?

  • The Mackenzie Emerging Markets Equity Index ETF share price today is $117.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and QEE.TO is experiencing selling pressure, which indicates risk of future bearish movement.

INKT Stock Price Chart

What is MiNK Therapeutics, Inc.'s stock price today?

  • The MiNK Therapeutics, Inc. share price today is $11.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.

QEE.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 16.55 Buy
Relative Strength Index (14 RSI): 41.44 Sell
Chaikin Money Flow: -1124 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (118 - 120.56) Sell
Bollinger Bands (100): (110.81 - 121.53) Buy

INKT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.18 Sell
Relative Strength Index (14 RSI): 44.15 Sell
Chaikin Money Flow: -6795 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.89 - 12.47) Sell
Bollinger Bands (100): (12.26 - 15.22) Sell

QEE.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 118.15 Sell
20-day SMA: 119.2 Sell
50-day SMA: 120.34 Sell
200-day SMA: 108.03 Buy
8-day EMA: 46.24 Buy
20-day EMA: 21.22 Buy
50-day EMA: 8.99 Buy
200-day EMA: 2.32 Buy

INKT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 12.26 Sell
20-day SMA: 11.59 Sell
50-day SMA: 12.86 Sell
200-day SMA: 11.87 Sell
8-day EMA: 11.94 Sell
20-day EMA: 12 Sell
50-day EMA: 12.64 Sell
200-day EMA: 12.22 Sell

Mackenzie Emerging Markets Equity Index ETF Earnings Growth & QEE.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

MiNK Therapeutics, Inc. Earnings Growth & INKT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.14 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and a decrease next year of $0.82 per share.

Mackenzie Emerging Markets Equity Index ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

MiNK Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):